126 related articles for article (PubMed ID: 25769449)
1. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes.
Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S
Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
[TBL] [Abstract][Full Text] [Related]
3. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer.
Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Grieu F; Watanabe G; Iacopetta B
Br J Cancer; 2006 Feb; 94(4):593-8. PubMed ID: 16421593
[TBL] [Abstract][Full Text] [Related]
6. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.
Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M
Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk.
Ho V; Ashbury JE; Taylor S; Vanner S; King WD
Environ Mol Mutagen; 2016 May; 57(4):261-8. PubMed ID: 27062459
[TBL] [Abstract][Full Text] [Related]
8. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study.
Chang KP; Hao SP; Tsang NM; Chang YL; Cheng MH; Liu CT; Lee YS; Tsai CL; Lee TJ; Wang TH; Tsai CN
Oncol Rep; 2008 Jan; 19(1):217-22. PubMed ID: 18097598
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
[TBL] [Abstract][Full Text] [Related]
10. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population.
Aung PP; Matsumura S; Kuraoka K; Kunimitsu K; Yoshida K; Matsusaki K; Nakayama H; Yasui W
Oncol Rep; 2005 Nov; 14(5):1151-4. PubMed ID: 16211278
[TBL] [Abstract][Full Text] [Related]
11. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
Huidobro C; Urdinguio RG; Rodríguez RM; Mangas C; Calvanese V; Martínez-Camblor P; Ferrero C; Parra-Blanco A; Rodrigo L; Obaya AJ; Suárez-Fernández L; Astudillo A; Hernando H; Ballestar E; Fernández AF; Fraga MF
Eur J Cancer; 2012 Sep; 48(14):2270-81. PubMed ID: 22244828
[TBL] [Abstract][Full Text] [Related]
12. Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: a case-control study.
Fan H; Zhang F; Hu J; Liu D; Zhao Z
J Exp Clin Cancer Res; 2008 Jul; 27(1):24. PubMed ID: 18662374
[TBL] [Abstract][Full Text] [Related]
13. The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancer.
Iacopetta B; Heyworth J; Girschik J; Grieu F; Clayforth C; Fritschi L
Int J Cancer; 2009 Jul; 125(1):84-90. PubMed ID: 19326430
[TBL] [Abstract][Full Text] [Related]
14. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
[TBL] [Abstract][Full Text] [Related]
15. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study.
Jaiswal SK; Sukla KK; Kumari N; Lakhotia AR; Kumar A; Rai AK
Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):299-305. PubMed ID: 25656965
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the promoter of DNMT3B is associated with the risk of colorectal cancer.
Bao Q; He B; Pan Y; Tang Z; Zhang Y; Qu L; Xu Y; Zhu C; Tian F; Wang S
Int J Colorectal Dis; 2011 Sep; 26(9):1107-12. PubMed ID: 21519807
[TBL] [Abstract][Full Text] [Related]
17. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
18. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome.
Coppedè F; Bosco P; Tannorella P; Romano C; Antonucci I; Stuppia L; Romano C; Migliore L
Hum Reprod; 2013 Feb; 28(2):545-50. PubMed ID: 23081874
[TBL] [Abstract][Full Text] [Related]
19. DNMT3B polymorphisms and risk of primary lung cancer.
Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
[TBL] [Abstract][Full Text] [Related]
20. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
Shen H; Wang L; Spitz MR; Hong WK; Mao L; Wei Q
Cancer Res; 2002 Sep; 62(17):4992-5. PubMed ID: 12208751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
